Minireviews
Copyright ©The Author(s) 2019.
World J Gastroenterol. Sep 7, 2019; 25(33): 4870-4884
Published online Sep 7, 2019. doi: 10.3748/wjg.v25.i33.4870
Table 2 Overview of studies on homB prevalence and clinical significance in adults and children
CountryStudy populationNumber of patientshomB prevalenceClinical relevance of homBAssociation with other virulence genes
Western countries[43]Adults23453.8Significant, PUDvacA s1, cagA+
East Asian countries[43]Adults13886.8NSNS
Western countries[46]Adults30056.0NANA
East Asian countries[46]Adults13886.6NANA
Burkina Faso[46]Adults1190.9NANA
Colombia, United States[47]Adults28661.2Significant, GCcagA+
Iran[45]Adults13843.5Significant, GCcagA+
Iraq[48]NA7029.9NSNS
Turkey[48]NA6433.9NSNS
South Korea[44]Children and adults26069.2NSvacA
Portugal[49]Children4558.4Significant, PUDNA
Adults9057.7NSNA
Portugal[42]Children8457.3Significant, PUDcagA+, vacA s1, babA2+, hopQI, oipA “on”
Adults10656.8Significant only in ≤ 40 yr of age, PUD
Portugal[22]Children11753.5Significant, PUDjhp0562
Slovenia[50]Children28540.7NSNS